Ada Tam

Research output

Research output per year 2002 2016 2017 2018 2019 2020 2021 2022 2023

• 43 Article
• 4 Comment/debate
• 1 Letter

Research output per year

Research output per year

Search results

• 2021

  Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers (Nature, (2021), 596, 7870, (126-132), 10.1038/s41586-021-03752-4)

  Caushi, J. X., Zhang, J., Ji, Z., Vaghasia, A., Zhang, B., Hsiue, E. H. C., Mog, B. J., Hou, W., Justesen, S., Blosser, R., Tam, A., Anagnostou, V., Cottrell, T. R., Guo, H., Chan, H. Y., Singh, D., Thapa, S., Dykema, A. G., Burman, P., Choudhury, B., & 35 othersAparicio, L., Cheung, L. S., Lanis, M., Belcaid, Z., El Asmar, M., Illei, P. B., Wang, R., Meyers, J., Schuebel, K., Gupta, A., Skaist, A., Wheelan, S., Naidoo, J., Marrone, K. A., Brock, M., Ha, J., Bush, E. L., Park, B. J., Bott, M., Jones, D. R., Reuss, J., Velculescu, V. E., Chaft, J. E., Kinzler, K. W., Zhou, S., Vogelstein, B., Taube, J. M., Hellmann, M. D., Brahmer, J. R., Merghoub, T., Forde, P. M., Yegnasubramanian, S., Ji, H., Pardoll, D. M. & Smith, K. N., Oct 21 2021, In: Nature. 598, 7881, p. E1

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Lung Neoplasms 100%
  • Names 89%
  • Genes 50%
  • Exome 37%
  • Memory 23%
• 2019

  Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (Journal for Immuno Therapy of Cancer (2019) 7 (40) DOI: 10.1186/s40425-018-0492-x)

  Smith, K. N., Llosa, N. J., Cottrell, T. R., Siegel, N., Fan, H., Suri, P., Chan, H. Y., Guo, H., Oke, T., Awan, A. H., Verde, F., Danilova, L., Anagnostou, V., Tam, A. J., Luber, B. S., Bartlett, B. R., Aulakh, L. K., Sidhom, J. W., Zhu, Q., Sears, C. L., & 21 othersCope, L., Sharfman, W. H., Thompson, E. D., Riemer, J., Marrone, K. A., Naidoo, J., Velculescu, V. E., Forde, P. M., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., Durham, J. N., Wang, H., Le, D. T., Justesen, S., Taube, J. M., Diaz, L. A., Brahmer, J. R., Pardoll, D. M., Anders, R. A. & Housseau, F., Mar 6 2019, In: Journal for immunotherapy of cancer. 7, 1, 7.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Consultants 100%
  • Oncogenes 88%
  • T-Lymphocytes 57%
  • Conflict of Interest 44%
  • Organized Financing 41%
  1 Scopus citations
• 2018

  Erratum: Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells (Cell Host & Microbe (2018) 23(2) (203–214.e5) (S1931312818300428) (10.1016/j.chom.2018.01.007))

  Chung, L., Orberg, E. T., Geis, A. L., Chan, J. L., Fu, K., DeStefano Shields, C. E., Dejea, C. M., Fathi, P., Chen, J., Finard, B. B., Tam, A. J., McAllister, F., Fan, H., Wu, X., Ganguly, S., Lebid, A., Metz, P., Van Meerbeke, S. W., Huso, D. L., Wick, E. C., & 5 othersPardoll, D. M., Wan, F., Wu, S., Sears, C. L. & Housseau, F., Mar 14 2018, In: Cell Host and Microbe. 23, 3, p. 421 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Bacteroides fragilis toxin 100%
  • Bacteroides fragilis 65%
  • Names 47%
  • epithelial cells 43%
  • toxins 41%
  18 Scopus citations
• 2016

  Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma [J Immunothera Cancer, 4, (2016), (28)] DOI:10.1186/s40425-016-0132-2

  Patel, M. A., Kim, J. E., Theodros, D., Tam, A., Velarde, E., Kochel, C. M., Francica, B., Nirschl, T. R., Ghasemzadeh, A., Mathios, D., Harris-Bookman, S., Jackson, C. C., Jackson, C., Ye, X., Tran, P. T., Tyler, B., Coric, V., Selby, M., Brem, H., Drake, C. G., & 2 othersPardoll, D. M. & Lim, M., Nov 4 2016, In: Journal for immunotherapy of cancer. 4, 1, 74.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Financial Support 100%
  • Radiosurgery 83%
  • Glioma 69%
  • Publications 62%
  • Monoclonal Antibodies 55%